Farallon Capital Management LLC Exact Sciences Corp Transaction History

Farallon Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$62.68 - $95.05 $37.7 Million - $57.2 Million	602,000 New	602,000 $56.5 Million
Q1 2022 May 16, 2022	BUY	$57.56 - $82.54 $27.7 Million - $39.7 Million	481,000 Added 149.43%	802,898 $56.1 Million
Q4 2021 Feb 14, 2022	SELL	$72.5 - $100.68 $20 Million - $27.8 Million	-275,700 Reduced 46.13%	321,898 $25.1 Million
Q3 2021 Nov 15, 2021	BUY	$90.24 - $124.05 $31.4 Million - $43.1 Million	347,598 Added 139.04%	597,598 $57 Million
Q2 2021 Aug 13, 2021	BUY	$93.66 - $139.27 $23.4 Million - $34.8 Million	250,000 New	250,000 $31.1 Million

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.3B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.